Iron addiction: a novel therapeutic target in ovarian cancer
Abstract
Ovarian cancer is a lethal malignancy that has not seen a major therapeutic advance in over 30 years. We demonstrate that ovarian cancer exhibits a targetable alteration in iron metabolism. Ferroportin (FPN), the iron efflux pump, is decreased, and transferrin receptor (TFR1), the iron importer, is increased in tumor tissue from patients with high grade but not low grade serous ovarian cancer. A similar profile of decreased FPN and increased TFR1 is observed in a genetic model of ovarian cancer tumor-initiating cells (TICs). The net result of these changes is an accumulation of excess intracellular iron and an augmented dependence on iron for proliferation. A forced reduction in intracellular iron reduces the proliferation of ovarian cancer TICs in vitro, and inhibits both tumor growth and intraperitoneal dissemination of tumor cells in vivo. Some mechanistic studies demonstrate that iron increases metastatic spread by facilitating invasion through expression of matrix metalloproteases and synthesis of interleukin 6 (IL-6). Here, we show that the iron dependence of ovarian cancer TICs renders them exquisitely sensitive in vivo to agents that induce iron-dependent cell death (ferroptosis) as well as iron chelators, and thus creates a metabolic vulnerability that can be exploited therapeutically.
- Authors:
-
- Univ. of Connecticut Health Center, Formington, CT (United States). Dept. of Molecular Biology and Biophysics
- National Cancer Center Research Inst., Tokyo (Japan)
- Jackson Lab. for Genomic Medicine, Farmington, CT (United States)
- Univ. of Texas Health Center, Houston, TX (United States). Center for Stem Cells and Regenerative Medicine
- Univ. of Houston, TX (United States). Dept. of Biology and Biochemistry
- Univ. of Connecticut Health Center, Farmington, CT (United States). Center for Quantitative Medicine
- Brigham and Women's Hospital (Harvard Medical School), Boston, MA (United States). Dept. of Pathology
- Univ. of Connecticut Health Center, Farmington, CT (United States). Dept. of Pathology
- Univ. of Connecticut Health Center, Farmington, CT (United States). Dept. of Obstetrics and Gynecology
- Wake Forest School of Medicine, Winston-Salem, NC (United States). Dept. of Cancer Biology
- Univ. of Connecticut Health Center, Farmington, CT (United States). Reconstructive Sciences
- Univ. of Connecticut Health Center, Farmington, CT (United States). Dept. of Medicine
- Publication Date:
- Research Org.:
- Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
- Sponsoring Org.:
- National Institutes of Health (NIH)
- OSTI Identifier:
- 1412859
- Report Number(s):
- LA-UR-17-20000
Journal ID: ISSN 0950-9232; TRN: US1800377
- Grant/Contract Number:
- AC52-06NA25396; R01 CA188025; R01 CA171101
- Resource Type:
- Accepted Manuscript
- Journal Name:
- Oncogene
- Additional Journal Information:
- Journal Volume: 36; Journal Issue: 29; Journal ID: ISSN 0950-9232
- Publisher:
- Nature Publishing Group
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 60 APPLIED LIFE SCIENCES; 59 BASIC BIOLOGICAL SCIENCES; Biological Science; ovarian cancer iron metabolism
Citation Formats
Basuli, D., Tesfay, L., Deng, Z., Paul, B., Yamamoto, Y., Ning, G., Xian, W., McKeon, F., Lynch, M., Crum, C. P., Hegde, P., Brewer, M., Wang, X., Miller, L. D., Dyment, N., Torti, F. M., and Torti, S. V. Iron addiction: a novel therapeutic target in ovarian cancer. United States: N. p., 2017.
Web. doi:10.1038/onc.2017.11.
Basuli, D., Tesfay, L., Deng, Z., Paul, B., Yamamoto, Y., Ning, G., Xian, W., McKeon, F., Lynch, M., Crum, C. P., Hegde, P., Brewer, M., Wang, X., Miller, L. D., Dyment, N., Torti, F. M., & Torti, S. V. Iron addiction: a novel therapeutic target in ovarian cancer. United States. https://doi.org/10.1038/onc.2017.11
Basuli, D., Tesfay, L., Deng, Z., Paul, B., Yamamoto, Y., Ning, G., Xian, W., McKeon, F., Lynch, M., Crum, C. P., Hegde, P., Brewer, M., Wang, X., Miller, L. D., Dyment, N., Torti, F. M., and Torti, S. V. Mon .
"Iron addiction: a novel therapeutic target in ovarian cancer". United States. https://doi.org/10.1038/onc.2017.11. https://www.osti.gov/servlets/purl/1412859.
@article{osti_1412859,
title = {Iron addiction: a novel therapeutic target in ovarian cancer},
author = {Basuli, D. and Tesfay, L. and Deng, Z. and Paul, B. and Yamamoto, Y. and Ning, G. and Xian, W. and McKeon, F. and Lynch, M. and Crum, C. P. and Hegde, P. and Brewer, M. and Wang, X. and Miller, L. D. and Dyment, N. and Torti, F. M. and Torti, S. V.},
abstractNote = {Ovarian cancer is a lethal malignancy that has not seen a major therapeutic advance in over 30 years. We demonstrate that ovarian cancer exhibits a targetable alteration in iron metabolism. Ferroportin (FPN), the iron efflux pump, is decreased, and transferrin receptor (TFR1), the iron importer, is increased in tumor tissue from patients with high grade but not low grade serous ovarian cancer. A similar profile of decreased FPN and increased TFR1 is observed in a genetic model of ovarian cancer tumor-initiating cells (TICs). The net result of these changes is an accumulation of excess intracellular iron and an augmented dependence on iron for proliferation. A forced reduction in intracellular iron reduces the proliferation of ovarian cancer TICs in vitro, and inhibits both tumor growth and intraperitoneal dissemination of tumor cells in vivo. Some mechanistic studies demonstrate that iron increases metastatic spread by facilitating invasion through expression of matrix metalloproteases and synthesis of interleukin 6 (IL-6). Here, we show that the iron dependence of ovarian cancer TICs renders them exquisitely sensitive in vivo to agents that induce iron-dependent cell death (ferroptosis) as well as iron chelators, and thus creates a metabolic vulnerability that can be exploited therapeutically.},
doi = {10.1038/onc.2017.11},
journal = {Oncogene},
number = 29,
volume = 36,
place = {United States},
year = {Mon Mar 20 00:00:00 EDT 2017},
month = {Mon Mar 20 00:00:00 EDT 2017}
}
Free Publicly Available Full Text
Publisher's Version of Record
Other availability
Search WorldCat to find libraries that may hold this journal
Cited by: 257 works
Citation information provided by
Web of Science
Web of Science
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.
Works referenced in this record:
Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells
journal, September 2009
- Kurrey, Nawneet K.; Jalgaonkar, Swati P.; Joglekar, Alok V.
- Stem Cells, Vol. 27, Issue 9
Iron and cancer: more ore to be mined
journal, April 2013
- Torti, Suzy V.; Torti, Frank M.
- Nature Reviews Cancer, Vol. 13, Issue 5
An Iron Regulatory Gene Signature Predicts Outcome in Breast Cancer
journal, August 2011
- Miller, L. D.; Coffman, L. G.; Chou, J. W.
- Cancer Research, Vol. 71, Issue 21
Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis
journal, August 2010
- Pinnix, Z. K.; Miller, L. D.; Wang, W.
- Science Translational Medicine, Vol. 2, Issue 43
Iron-induced interleukin-6 gene expression: possible mediation through the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways
journal, October 2004
- Dai, Jisen; Huang, Chuanshu; Wu, Jing
- Toxicology, Vol. 203, Issue 1-3
Ovarian Cancer Pathogenesis: A Model in Evolution
journal, January 2010
- Karst, Alison M.; Drapkin, Ronny
- Journal of Oncology, Vol. 2010
Regulation of Ferroptotic Cancer Cell Death by GPX4
journal, January 2014
- Yang, Wan Seok; SriRamaratnam, Rohitha; Welsch, Matthew E.
- Cell, Vol. 156, Issue 1-2
The biology of ovarian cancer: new opportunities for translation
journal, June 2009
- Bast, Robert C.; Hennessy, Bryan; Mills, Gordon B.
- Nature Reviews Cancer, Vol. 9, Issue 6
Modeling high-grade serous ovarian carcinogenesis from the fallopian tube
journal, April 2011
- Karst, A. M.; Levanon, K.; Drapkin, R.
- Proceedings of the National Academy of Sciences, Vol. 108, Issue 18
Ovarian cancer stem cells: Are they real and why are they important?
journal, February 2014
- Shah, Monjri M.; Landen, Charles N.
- Gynecologic Oncology, Vol. 132, Issue 2
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
journal, February 2010
- Ahmed, Ahmed Ashour; Etemadmoghadam, Dariush; Temple, Jillian
- The Journal of Pathology, Vol. 221, Issue 1
Ferroptosis: Death by Lipid Peroxidation
journal, March 2016
- Yang, Wan Seok; Stockwell, Brent R.
- Trends in Cell Biology, Vol. 26, Issue 3
In vitro and in vivo correlates of physiological and neoplastic human Fallopian tube stem cells
journal, January 2016
- Yamamoto, Yusuke; Ning, Gang; Howitt, Brooke E.
- The Journal of Pathology, Vol. 238, Issue 4
Novel Thiosemicarbazones Regulate the Signal Transducer and Activator of Transcription 3 (STAT3) Pathway: Inhibition of Constitutive and Interleukin 6–Induced Activation by Iron Depletion
journal, January 2015
- Lui, Goldie Y. L.; Kovacevic, Zaklina; V. Menezes, Sharleen
- Molecular Pharmacology, Vol. 87, Issue 3
Iron and cancer: recent insights: Iron and cancer
journal, February 2016
- Manz, David H.; Blanchette, Nicole L.; Paul, Bibbin T.
- Annals of the New York Academy of Sciences, Vol. 1368, Issue 1
Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
journal, April 2011
- Silva, I. A.; Bai, S.; McLean, K.
- Cancer Research, Vol. 71, Issue 11
c-myc amplification in ovarian cancer
journal, September 1990
- Baker, Vicki V.; Borst, Matthew P.; Dixon, Diane
- Gynecologic Oncology, Vol. 38, Issue 3
Ironing Out Cell Death Mechanisms
journal, May 2012
- Reed, John C.; Pellecchia, Maurizio
- Cell, Vol. 149, Issue 5
Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube
journal, October 2013
- Dietl, Johannes
- Archives of Gynecology and Obstetrics, Vol. 289, Issue 2
Ovary and fimbrial stem cells: biology, niche and cancer origins
journal, September 2015
- Ng, Annie; Barker, Nick
- Nature Reviews Molecular Cell Biology, Vol. 16, Issue 10
Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
journal, October 2010
- Landen, C. N.; Goodman, B.; Katre, A. A.
- Molecular Cancer Therapeutics, Vol. 9, Issue 12
Functional consequences of ferroportin 1 mutations
journal, July 2005
- Liu, Xiao-Bing; Yang, Funmei; Haile, David J.
- Blood Cells, Molecules, and Diseases, Vol. 35, Issue 1
Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer
journal, August 2012
- M. Dijkgraaf, Eveline; J. P. Welters, Marij; W. R. Nortier, Johan
- Current Pharmaceutical Design, Vol. 18, Issue 25
Ovarian Cancer Development and Metastasis
journal, September 2010
- Lengyel, Ernst
- The American Journal of Pathology, Vol. 177, Issue 3
Efficient molecular subtype classification of high-grade serous ovarian cancer: Molecular subtype classification of ovarian cancer
journal, April 2015
- Leong, Huei San; Galletta, Laura; Etemadmoghadam, Dariush
- The Journal of Pathology, Vol. 236, Issue 3
The PAX2-null immunophenotype defines multiple lineages with common expression signatures in benign and neoplastic oviductal epithelium: Progenitor cells in the Fallopian tube
journal, September 2014
- Ning, Gang; Bijron, Jonathan G.; Yamamoto, Yusuke
- The Journal of Pathology, Vol. 234, Issue 4
In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations
journal, May 2005
- Schimanski, Lisa M.; Drakesmith, Hal; Merryweather-Clarke, Alison T.
- Blood, Vol. 105, Issue 10
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
journal, May 2012
- Dixon, Scott J.; Lemberg, Kathryn M.; Lamprecht, Michael R.
- Cell, Vol. 149, Issue 5
Origin and molecular pathogenesis of ovarian high-grade serous carcinoma
journal, November 2013
- Kurman, R. J.
- Annals of Oncology, Vol. 24, Issue suppl 10
Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells
journal, March 2003
- Dolma, Sonam; Lessnick, Stephen L.; Hahn, William C.
- Cancer Cell, Vol. 3, Issue 3
Molecular Mechanism of Hepcidin-Mediated Ferroportin Internalization Requires Ferroportin Lysines, Not Tyrosines or JAK-STAT
journal, June 2012
- Ross, Sandra L.; Tran, Lynn; Winters, Aaron
- Cell Metabolism, Vol. 15, Issue 6
The Life and Times of Low-Grade Serous Carcinoma of the Ovary
journal, January 2013
- Gershenson, David M.
- American Society of Clinical Oncology Educational Book, Vol. 33
The role of iron and reactive oxygen species in cell death
journal, December 2013
- Dixon, Scott J.; Stockwell, Brent R.
- Nature Chemical Biology, Vol. 10, Issue 1
Evaluating cell lines as tumour models by comparison of genomic profiles
journal, July 2013
- Domcke, Silvia; Sinha, Rileen; Levine, Douglas A.
- Nature Communications, Vol. 4, Issue 1
Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells
journal, October 2015
- Schonberg, David L.; Miller, Tyler E.; Wu, Qiulian
- Cancer Cell, Vol. 28, Issue 4
IRP2 Regulates Breast Tumor Growth
journal, November 2013
- Wang, Wei; Deng, Zhiyong; Hatcher, Heather
- Cancer Research, Vol. 74, Issue 2
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
journal, October 2008
- Baba, T.; Convery, P. A.; Matsumura, N.
- Oncogene, Vol. 28, Issue 2
IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3′-diindolylmethane in ovarian cancer cells
journal, October 2015
- Zou, Minghua; Zhang, Xianquan; Xu, Changhua
- Cellular Oncology, Vol. 39, Issue 1
Quantifying chromogen intensity in immunohistochemistry via reciprocal intensity.
journal, December 2013
- Nguyen, David; Nguyen, David
- Protocol Exchange
In vitro and in vivo correlates of physiological and neoplastic human Fallopian tube stem cells
journal, January 2016
- Yamamoto, Yusuke; Ning, Gang; Howitt, Brooke E.
- The Journal of Pathology, Vol. 238, Issue 4
Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube
journal, October 2013
- Dietl, Johannes
- Archives of Gynecology and Obstetrics, Vol. 289, Issue 2
Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells
journal, October 2015
- Schonberg, David L.; Miller, Tyler E.; Wu, Qiulian
- Cancer Cell, Vol. 28, Issue 4
Ironing Out Cell Death Mechanisms
journal, May 2012
- Reed, John C.; Pellecchia, Maurizio
- Cell, Vol. 149, Issue 5
Regulation of Ferroptotic Cancer Cell Death by GPX4
journal, January 2014
- Yang, Wan Seok; SriRamaratnam, Rohitha; Welsch, Matthew E.
- Cell, Vol. 156, Issue 1-2
Molecular Mechanism of Hepcidin-Mediated Ferroportin Internalization Requires Ferroportin Lysines, Not Tyrosines or JAK-STAT
journal, June 2012
- Ross, Sandra L.; Tran, Lynn; Winters, Aaron
- Cell Metabolism, Vol. 15, Issue 6
Iron-induced interleukin-6 gene expression: possible mediation through the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways
journal, October 2004
- Dai, Jisen; Huang, Chuanshu; Wu, Jing
- Toxicology, Vol. 203, Issue 1-3
Ovarian cancer stem cells: Are they real and why are they important?
journal, February 2014
- Shah, Monjri M.; Landen, Charles N.
- Gynecologic Oncology, Vol. 132, Issue 2
The biology of ovarian cancer: new opportunities for translation
journal, June 2009
- Bast, Robert C.; Hennessy, Bryan; Mills, Gordon B.
- Nature Reviews Cancer, Vol. 9, Issue 6
Iron and cancer: more ore to be mined
journal, April 2013
- Torti, Suzy V.; Torti, Frank M.
- Nature Reviews Cancer, Vol. 13, Issue 5
Ovary and fimbrial stem cells: biology, niche and cancer origins
journal, September 2015
- Ng, Annie; Barker, Nick
- Nature Reviews Molecular Cell Biology, Vol. 16, Issue 10
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
journal, October 2008
- Baba, T.; Convery, P. A.; Matsumura, N.
- Oncogene, Vol. 28, Issue 2
Origin and molecular pathogenesis of ovarian high-grade serous carcinoma
journal, November 2013
- Kurman, R. J.
- Annals of Oncology, Vol. 24, Issue suppl 10
Novel Thiosemicarbazones Regulate the Signal Transducer and Activator of Transcription 3 (STAT3) Pathway: Inhibition of Constitutive and Interleukin 6–Induced Activation by Iron Depletion
journal, January 2015
- Lui, Goldie Y. L.; Kovacevic, Zaklina; V. Menezes, Sharleen
- Molecular Pharmacology, Vol. 87, Issue 3
PIASy-Mediated Sumoylation of Yin Yang 1 Depends on Their Interaction but Not the RING Finger
journal, March 2007
- Deng, Z.; Wan, M.; Sui, G.
- Molecular and Cellular Biology, Vol. 27, Issue 10
Ovarian Cancer Pathogenesis: A Model in Evolution
journal, January 2010
- Karst, Alison M.; Drapkin, Ronny
- Journal of Oncology, Vol. 2010
Ironing Out Cancer: Figure 1.
journal, March 2011
- Torti, Suzy V.; Torti, Frank M.
- Cancer Research, Vol. 71, Issue 5
Hepcidin Regulation in Prostate and Its Disruption in Prostate Cancer
journal, April 2015
- Tesfay, Lia; Clausen, Kathryn A.; Kim, Jin Woo
- Cancer Research, Vol. 75, Issue 11
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
journal, August 2008
- Tothill, R. W.; Tinker, A. V.; George, J.
- Clinical Cancer Research, Vol. 14, Issue 16
Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
journal, July 2011
- Coward, Jermaine; Kulbe, Hagen; Chakravarty, Probir
- Clinical Cancer Research, Vol. 17, Issue 18
In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations
journal, May 2005
- Schimanski, Lisa M.; Drakesmith, Hal; Merryweather-Clarke, Alison T.
- Blood, Vol. 105, Issue 10
Regulation of ferritin genes and protein
journal, May 2002
- Torti, Frank M.; Torti, Suzy V.
- Blood, Vol. 99, Issue 10
The Life and Times of Low-Grade Serous Carcinoma of the Ovary
journal, May 2013
- Gershenson, David M.
- American Society of Clinical Oncology Educational Book, Issue 33
Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer
journal, August 2012
- M. Dijkgraaf, Eveline; J. P. Welters, Marij; W. R. Nortier, Johan
- Current Pharmaceutical Design, Vol. 18, Issue 25
An iron regulatory gene signature in breast cancer: more than a prognostic genetic profile?
journal, February 2012
- Nicolini, Andrea; Ferrari, Paola; Fallahi, Pupak
- Future Oncology, Vol. 8, Issue 2
Works referencing / citing this record:
Quantitative characterization of the regulation of iron metabolism in glioblastoma stem‐like cells using magnetophoresis
journal, April 2019
- Park, Kyoung‐Joo J.; Kim, James; Testoff, Thomas
- Biotechnology and Bioengineering, Vol. 116, Issue 7
Salinomycin Derivatives Kill Breast Cancer Stem Cells by Lysosomal Iron Targeting
journal, April 2020
- Versini, Antoine; Colombeau, Ludovic; Hienzsch, Antje
- Chemistry – A European Journal, Vol. 26, Issue 33
Ferritinophagy/ferroptosis: Iron‐related newcomers in human diseases
journal, June 2018
- Tang, Mingzhu; Chen, Zhe; Wu, Di
- Journal of Cellular Physiology, Vol. 233, Issue 12
The role of iron metabolism in cancer therapy focusing on tumor‐associated macrophages
journal, October 2018
- Dong, Dandan; Zhang, Gejing; Yang, Jiancheng
- Journal of Cellular Physiology, Vol. 234, Issue 6
Advances in the antimicrobial and therapeutic potential of siderophores
journal, May 2019
- Ribeiro, Marta; Simões, Manuel
- Environmental Chemistry Letters, Vol. 17, Issue 4
Ferroptosis: past, present and future
journal, February 2020
- Li, Jie; Cao, Feng; Yin, He-liang
- Cell Death & Disease, Vol. 11, Issue 2
FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels
journal, March 2019
- Trujillo-Alonso, Vicenta; Pratt, Edwin C.; Zong, Hongliang
- Nature Nanotechnology, Vol. 14, Issue 6
The chemical basis of ferroptosis
journal, November 2019
- Conrad, Marcus; Pratt, Derek A.
- Nature Chemical Biology, Vol. 15, Issue 12
A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions
journal, February 2019
- Neiveyans, Madeline; Melhem, Rana; Arnoult, Christophe
- mAbs, Vol. 11, Issue 3
CD44 regulates epigenetic plasticity by mediating iron endocytosis
posted_content, July 2019
- Müller, Sebastian; Sindikubwabo, Fabien; Cañeque, Tatiana
- Nature Chemistry
Molecular mechanisms of ferroptosis and its role in cancer therapy
journal, June 2019
- Xu, Tao; Ding, Wei; Ji, Xiaoyu
- Journal of Cellular and Molecular Medicine, Vol. 23, Issue 8
Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma
journal, May 2019
- Vicent, Silvestre; Lieshout, Ruby; Saborowski, Anna
- Liver International, Vol. 39, Issue S1
Antioxidant Defenses: A Context-Specific Vulnerability of Cancer Cells
journal, August 2019
- Cockfield, Jordan A.; Schafer, Zachary T.
- Cancers, Vol. 11, Issue 8
Iron, Oxidative Damage and Ferroptosis in Rhabdomyosarcoma
journal, August 2017
- Fanzani, Alessandro; Poli, Maura
- International Journal of Molecular Sciences, Vol. 18, Issue 8, p. 1718
Deferoxamine Enhanced Mitochondrial Iron Accumulation and Promoted Cell Migration in Triple-Negative MDA-MB-231 Breast Cancer Cells Via a ROS-Dependent Mechanism
journal, October 2019
- Chen, Chunli; Wang, Shicheng; Liu, Ping
- International Journal of Molecular Sciences, Vol. 20, Issue 19
The Role of NCOA4-Mediated Ferritinophagy in Health and Disease
journal, October 2018
- Santana-Codina, Naiara; Mancias, Joseph
- Pharmaceuticals, Vol. 11, Issue 4
Engineered stem cells targeting multiple cell surface receptors in tumors: ENGINEERED STEM CELLS FOR TARGETED CANCER THERAPY
journal, August 2019
- Kavari, Sanam L.; Shah, Khalid
- STEM CELLS, Vol. 38, Issue 1
Necroptotic cell death in anti-cancer therapy
journal, October 2017
- Krysko, Olga; Aaes, Tania Løve; Kagan, Valerian E.
- Immunological Reviews, Vol. 280, Issue 1
Ferroptosis, a new form of cell death: opportunities and challenges in cancer
journal, March 2019
- Mou, Yanhua; Wang, Jun; Wu, Jinchun
- Journal of Hematology & Oncology, Vol. 12, Issue 1
Links Between Iron and Lipids: Implications in Some Major Human Diseases
journal, October 2018
- Rockfield, Stephanie; Chhabra, Ravneet; Robertson, Michelle
- Pharmaceuticals, Vol. 11, Issue 4
α-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice
journal, April 2018
- Zhang, Yan-Hui; Wang, Da-Wei; Xu, Shuang-Feng
- Redox Biology, Vol. 14
Chronic iron exposure and c-Myc/H-ras-mediated transformation in fallopian tube cells alter the expression of EVI1, amplified at 3q26.2 in ovarian cancer
journal, August 2019
- Rockfield, Stephanie; Kee, Younghoon; Nanjundan, Meera
- Oncogenesis, Vol. 8, Issue 9
Ferroptosis: past, present and future
journal, February 2020
- Li, Jie; Cao, Feng; Yin, He-liang
- Cell Death & Disease, Vol. 11, Issue 2
Winning the war with iron
journal, March 2019
- Torti, Suzy V.; Torti, Frank M.
- Nature Nanotechnology, Vol. 14, Issue 6
A Systems Biology Approach to Understanding the Pathophysiology of High-Grade Serous Ovarian Cancer: Focus on Iron and Fatty Acid Metabolism
journal, July 2018
- Konstorum, Anna; Lynch, Miranda L.; Torti, Suzy V.
- OMICS: A Journal of Integrative Biology, Vol. 22, Issue 7
Ferroptosis: Final destination for cancer?
journal, February 2020
- Ye, Zeng; Liu, Wensheng; Zhuo, Qifeng
- Cell Proliferation, Vol. 53, Issue 3
Molecular mechanisms of ferroptosis and its role in cancer therapy
journal, June 2019
- Xu, Tao; Ding, Wei; Ji, Xiaoyu
- Journal of Cellular and Molecular Medicine, Vol. 23, Issue 8
Ferroptosis, a new form of cell death: opportunities and challenges in cancer
journal, March 2019
- Mou, Yanhua; Wang, Jun; Wu, Jinchun
- Journal of Hematology & Oncology, Vol. 12, Issue 1
Iron-responsive element-binding protein 2 plays an essential role in regulating prostate cancer cell growth
journal, July 2017
- Deng, Zhiyong; Manz, David H.; Torti, Suzy V.
- Oncotarget, Vol. 8, Issue 47
Serum ferritin and primary lung cancer
journal, October 2017
- Chen, Zhongqing; Zhu, Bo; Ou, Chao
- Oncotarget, Vol. 8, Issue 54
Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators
journal, May 2019
- Cheng, Gang; Zielonka, Jacek; Hardy, Micael
- Oncotarget, Vol. 10, Issue 37
The crosstalk between autophagy and ferroptosis: what can we learn to target drug resistance in cancer?
journal, November 2019
- Zhou, Yulu; Shen, Yong; Chen, Cong
- Cancer Biology & Medicine, Vol. 16, Issue 4
Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer
journal, December 2019
- Zhou, Hai-Hong; Chen, Xu; Cai, Lu-Ya
- Frontiers in Oncology, Vol. 9
Antioxidant Defenses: A Context-Specific Vulnerability of Cancer Cells
journal, August 2019
- Cockfield, Jordan A.; Schafer, Zachary T.
- Cancers, Vol. 11, Issue 8
Deferoxamine Enhanced Mitochondrial Iron Accumulation and Promoted Cell Migration in Triple-Negative MDA-MB-231 Breast Cancer Cells Via a ROS-Dependent Mechanism
journal, October 2019
- Chen, Chunli; Wang, Shicheng; Liu, Ping
- International Journal of Molecular Sciences, Vol. 20, Issue 19
Protein Expression of Cyclin B1, Transferrin Receptor, and Fibronectin Is Correlated with the Prognosis of Adrenal Cortical Carcinoma
journal, January 2020
- Moon, Sun Joon; Kim, Jung Hee; Kong, Sung Hye
- Endocrinology and Metabolism, Vol. 35, Issue 1